From: Human iPSC-derived glia models for the study of neuroinflammation
Stimulus | Stimulus concentration | Stimulus time | Method | Measure of inflammation | References |
---|---|---|---|---|---|
LPS | 10Â ng/mL | 4Â h | RT-qPCR | Increased IL1B, IL6 Decreased CX3CR1, TREM2, CD33, CSF1R | [66] |
ELISA | Increased IL-6 | [66] | |||
50Â ng/mL | 24Â h | RT-qPCR | Increased IL1B, CCL2, TNFAIP3 | [68] | |
100Â ng/mL | 3Â h | RT-qPCR | Increased IL1B, IL10, NLRP3 | [67] | |
Western Blot | Increased NLRP3 | [67] | |||
4Â h | RT-qPCR | Increased IL1B Decreased CX3CR1, TREM2, CD33, CSF1R | [66] | ||
ELISA | Increased IL-6, IL1B | [66] | |||
8Â h | RT-qPCR | Increased IL1B | [69] | ||
18Â h | RNA sequencing | Increased IL1B, TNF, IL6 | [70] | ||
RT-qPCR | Increased IL1B, IL6 | [70] | |||
24 h | Multiplexed ELISA | Increased TNF, IL-6, IL-8, IL-10, IL-1α, CCL2, CCL4, CXCL10, CCL17 | [53] | ||
Multiplexed ELISA | Increased IL-1β, IL-6 | [71] | |||
Profiler human cytokine kit | Increased TNF, Serpin E1, IL-8, IL-6, IL-1Rα, IL-1β, ICAM-1, CXCL10, CXCL1, CCL5, CCL2, CCL1 | [58] | |||
Human magnetic Luminex assay | Increased IL-6, TNF, IL-10, CCL2, CCL3, CCL4, CCL5, CXCL1, CXCL2 | [72] | |||
Cytometric bead array | Increased IL-6, MCP-1, IL-8, RANTES, GM-CSF, TNF | [60] | |||
1 µg/mL | 24 h | RT-qPCR | Increased IL6 | [73] | |
ELISA | Increased IL-6 | [73] | |||
IFN-γ | 10 ng/mL | 24 h | Human magnetic Luminex assay | Measured 10 cytokines, no change detected | [72] |
20Â ng/mL | 24Â h | Multiplexed ELISA | Increased TNF, IL-8, CCL2, CCL3, CCL4, CCL17 | [53] | |
Cytometric bead array | Increased IL-6, MCP-1, IL-8 | [60] | |||
LPS and IFN-γ | 100 ng/mL LPS and 10 ng/mL IFN-γ | 24 h | Human magnetic Luminex assay | Increased TNF, CCL2, CCL3, CCL4, RANTES | [72] |
100 ng/mL LPS and 20 ng/mL IFN-γ | 24 h | RT-qPCR | Increased TNF and IL6 | [62] | |
RT-qPCR | Increased TNF, IL6, IL1B | [75] | |||
Cytokine antibody panel membrane | Increased MIPα/β, TNF, IL-6, IFN-γ, CXCL1, CXCL10 | [62] | |||
Human cytokine array kit | Increased CCL2, MIPα, IL-6, IL-8, PA1-1, CXCL1, CXCL10 | [75] | |||
Multiplexed ELISA | Increased IL-1β, TNF, IL-6 | [71] | |||
Cytometric bead array | Increased IL-6, TNF, MCP-1, IL-8, RANTES, GM-CSF | [60] | |||
48 h | Cytometric bead array | Increased IL12p40, IL12p70, IL-6, IL-4, IL-10, IL-1RA, TARC, TNF, IFN-γ, IL-23 | [76] | ||
IL-1β | 20 ng/mL | 24 h | Multiplexed ELISA | Increased TNF, IL-8, CCL3, CCL4, CXCL10, CCL17 | [53] |
Amyloid-beta (Aβ1–42) | 1 µM | 24 h | RT-qPCR | Increased TNF, IL6, IL1B, RELA | [73] |
Amyloid-beta fibrils (Aβ-F) | 0.2 µM | 24 h | Cytokine array | Measured 36 human chemokines and cytokines, no change detected | [79] |
Amyloid-beta oligomers (AβO) | 3 µM | 24 h | RT-qPCR | Increased TNF, IL6, IL1B | [78] |
α-Synuclein monomers | 750 nM | 6 h | ELISA | Increased IL-6, TNF | [66] |
α-Synuclein oligomers | 750 nM | 6 h | ELISA | Increased IL-1β, caspase-1, IL-6, TNF | [66] |
α-Synuclein fibrils (αSYN-F) | 0.5 µM | 24 h | Cytokine array | Measured 36 human chemokines and cytokines, no change detected | [79] |